A new and distinct cultivar of
Angelonia
plant named ‘Ansupi’ characterized by its broadly upright plant habit; vigorous growth habit; freely flowering habit; large light purple-colored flowers with white-colored centers; and suitable as a cut flower with good postproduction longevity.
Medicinal compositions and methods of use involving phosphoric acid
申请人:Aktiebolaget Leo
公开号:US03991187A1
公开(公告)日:1976-11-09
Novel symmetrical secondary phosphoric acid esters having the general formula ##SPC1## Wherein the substituent R is positioned in meta or para position relative to the phosphoric acid ester group; processes for the preparation of said esters; and compositions containing said esters. The esters are i.a. useful as selective inhibitors of prostaglandins and compounds with prostaglandin activities. They also selectively antagonize the slow reacting substance (SRS).
Secondary phosphoric acid esters, composition and method of use
申请人:Aktiebolaget Leo
公开号:US03995033A1
公开(公告)日:1976-11-30
This invention relates to novel secondary phosphoric acid esters and salts thereof, having valuable pharmacological properties, and to the preparation thereof. The invention is also concerned with pharmaceutical compositions containing the said compounds, and methods of treatment therewith. The esters are i.a. useful as selective inhibitors of prostaglandins and of Slow Reacting Substances (SRS). They also inhibit the formation of adenosine 3',5'-monophosphate (cyclic AMP). In addition the esters of this invention also exert intrinsic smooth muscle stimulatory activity.
Method, composition and compounds for treating excess prostaglandins
申请人:Aktiebolaget Leo
公开号:US04049800A1
公开(公告)日:1977-09-20
This invention relates to novel secondary phosphoric acid esters and salts thereof, having valuable pharmacological properties, and to the preparation thereof. The invention is also concerned with pharmaceutical compositions containing the said compounds, and methods of treatment therewith. The esters are i.a. useful as selective inhibitors of prostaglandins and of Slow Reacting Substances (SRS). They also inhibit the formation of adenosine 3',5'-monophosphate (cyclic AMP). In addition the esters of this invention also exert intrinsic smooth muscle stimulatory activity.